Inventor
SEBTI SAID M
US95 patents
⚠️ This page may combine multiple inventors who share the name “SEBTI SAID M”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV SOUTH FLORIDA
13 patentsUS5849790ADec 15, 1998
(Mono) ethylenediaminenitroplatinum (IV) complexes with ligands of oxides of nitrogen as possible anti-tumor agents
UNIV SOUTH FLORIDA45 citations89
US7713960B2May 11, 2010
Inhibition of the Raf/Mek/P-Erk pathway for treating cancer
UNIV SOUTH FLORIDA8 citations84
US7977381B2Jul 12, 2011
Platinum complexes and methods for inhibiting tumor cell proliferation
UNIV SOUTH FLORIDA8 citations83
US7960434B2Jun 14, 2011
Small molecule inhibitors of STAT3 with anti-tumor activity
UNIV SOUTH FLORIDA10 citations81
US6531645B1Mar 11, 2003
RAS/P21 transgenic mouse
UNIV SOUTH FLORIDA10 citations64
US9115162B2Aug 25, 2015
Effective treatment of tumors and cancer with triciribine and related compounds
UNIV SOUTH FLORIDA2 citations63
US7342095B2Mar 11, 2008
Peptidomimetic inhibitors of STAT activity and uses thereof
UNIV SOUTH FLORIDA3 citations63
US8846653B2Sep 30, 2014
Delta-tocotrienol treatment and prevention of pancreatic cancer
UNIV SOUTH FLORIDA2 citations60
US10780104B2Sep 22, 2020
Compositions including triciribine and epidermal growth factor receptor inhibitor compounds or salts thereof and methods of use thereof
UNIV SOUTH FLORIDA0 citations52
US10744148B2Aug 18, 2020
Methods of treating breast cancer that overexpress AKT kinase
UNIV SOUTH FLORIDA0 citations52
US9655914B2May 23, 2017
Compositions including triciribine and epidermal growth factor receptor inhibitor compounds or salts thereof and methods of use thereof
UNIV SOUTH FLORIDA0 citations52
US9518079B2Dec 13, 2016
Effective treatment of tumors and cancer with triciribine and related compounds
UNIV SOUTH FLORIDA0 citations52
US9511084B2Dec 6, 2016
Compositions including triciribine and methods of use thereof
UNIV SOUTH FLORIDA1 citations52
H LEE MOFFITT CANCER CT & RES
12 patentsUS9040563B2May 26, 2015
Dual inhibitors of farnesyltransferase and geranylgeranyltransferase I
H LEE MOFFITT CANCER CT & RES2 citations63
US11571418B2Feb 7, 2023
Platinum compounds that inhibit constitutive STAT3 signaling and induce cell cycle arrest and apoptosis of malignant cells
H LEE MOFFITT CANCER CT & RES0 citations62
US9968599B2May 15, 2018
Platinum compounds that inhibit constitutive STAT3 signaling and induce cell cycle arrest and apoptosis of malignant cells
H LEE MOFFITT CANCER CT & RES1 citations62
US10954258B2Mar 23, 2021
STAT3 dimerization inhibitors
H LEE MOFFITT CANCER CT & RES0 citations61
US11352370B2Jun 7, 2022
Mutant KRAS inhibitors
H LEE MOFFITT CANCER CT & RES0 citations60
US12060332B2Aug 13, 2024
Aurora kinase and janus kinase inhibitors for prevention of graft versus host disease
H LEE MOFFITT CANCER CT & RES0 citations58
US11203576B2Dec 21, 2021
Aurora kinase and Janus kinase inhibitors for prevention of graft versus host disease
H LEE MOFFITT CANCER CT & RES0 citations58
US11583525B2Feb 21, 2023
Geranylgeranyltransferase I inhibitor for treatment of a PTEN defective cancer
H LEE MOFFITT CANCER CT & RES0 citations55
US10813927B2Oct 27, 2020
Platinum compounds that inhibit constitutive STAT3 signaling and induce cell cycle arrest and apoptosis of malignant cells
H LEE MOFFITT CANCER CT & RES0 citations52
US10507228B2Dec 17, 2019
Methods and compositions related to KRAS inhibitors
H LEE MOFFITT CANCER CT & RES0 citations52
US10351596B2Jul 16, 2019
γ-AA-peptide STAT3/DNA inhibitors and methods of use
H LEE MOFFITT CANCER CT & RES0 citations52
US10000531B2Jun 19, 2018
Gamma-AA-peptide STAT3/DNA inhibitors and methods of use
H LEE MOFFITT CANCER CT & RES0 citations52
UNIV PITTSBURGH
7 patentsUS6221865B1Apr 24, 2001
Inhibitors of protein isoprenyl transferases
UNIV PITTSBURGH30 citations92
US6204293B1Mar 20, 2001
Inhibitors of protein isoprenyl transferases
UNIV PITTSBURGH26 citations92
US6310095B1Oct 30, 2001
Inhibitors of protein isoprenyl transferases
UNIV PITTSBURGH39 citations91
US6083979AJul 4, 2000
Geranylgeraniol/lovastatin: a novel approach to blocking cancer transformation without cytotoxicity
UNIV PITTSBURGH22 citations86
US5834434ANov 10, 1998
Inhibitors of farnesyltransferase
UNIV PITTSBURGH18 citations84
US6693123B2Feb 17, 2004
Inhibitors of protein isoprenyl transferases
UNIV PITTSBURGH7 citations73
US5420228AMay 30, 1995
Fluorescent-labelled bleomycin analogues
UNIV PITTSBURGH5 citations54
SEBTI SAID M
7 patentsUS8642278B2Feb 4, 2014
Inhibition of cell proliferation
SEBTI SAID M7 citations82
US9597329B2Mar 21, 2017
Aurora kinase inhibitors and methods of making and using thereof
SEBTI SAID M4 citations69
US10946012B2Mar 16, 2021
Methods for inducing tumor regression, inhibiting tumor growth, and inducing apoptosis in breast tumors with geranylgeranyltransferase I inhibitors
SEBTI SAID M0 citations62
US8828451B2Sep 9, 2014
Akt sensitization of cancer cells
SEBTI SAID M2 citations62
US8691799B2Apr 8, 2014
Materials and methods for treatment of cancer and identification of anti-cancer compounds
SEBTI SAID M2 citations62
US9453049B2Sep 27, 2016
Substrate-mimetic Akt inhibitor
SEBTI SAID M1 citations60
US8822524B2Sep 2, 2014
Substrate-mimetic Akt inhibitor
SEBTI SAID M1 citations60
CHENG JIN Q
4 patentsUS8435959B2May 7, 2013
Effective treatment of tumors and cancer with triciribine and related compounds
CHENG JIN Q12 citations84
US8183249B2May 22, 2012
Inhibitors of AKT/PKB with anti-tumor activity
CHENG JIN Q8 citations83
US8901086B2Dec 2, 2014
Compositions including triciribine and methods of use thereof
CHENG JIN Q2 citations62
US8623834B2Jan 7, 2014
Compositions including triciribine and trastuzumab and methods of use thereof
CHENG JIN Q2 citations62
LAWRENCE HARSHANI
2 patentsLAWRENCE NICHOLAS J
2 patentsKAY HEIDI
1 patentUNIV SOUTH FLORIDA BOARD OF TR
1 patentMALAFA MOKENGE P
1 patentShowing the top 50 of 95 patents by PatentIndex Score.